Contineum Therapeutics, Inc. (CTNM) Earnings
|
Expand Research on CTNM
| Next EPS Date | 8/6/26 *Est. | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -42.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +2.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/14/26  |
Q126 | N/A | -$0.85 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/5/26 | Q425 | -$0.49 | -$0.65 | +$0.16 | N/A | N/A | N/A |  | | Details | |
| 11/5/25 |
Q325 | N/A | -$0.60 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 10/30/25 |
Q325 | N/A | -$0.60 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/6/25 |
Q225 | -$0.62 | -$0.28 | -$0.34 | N/A | N/A | N/A | | | Details | |
| 5/15/25 |
Q125 | -$0.62 | -$0.42 | -$0.20 | N/A | N/A | N/A | | | Details | |
| 3/7/25 |
Q424 | -$0.56 | -$0.45 | -$0.11 | N/A | N/A | N/A | | | Details | |
| 11/27/24 |
Q324 | N/A | -$0.36 | N/A | N/A | N/A | N/A | N/A | N/A |
